A citation-based method for searching scientific literature

Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
Times Cited: 296



Diana Mandelker, Liying Zhang, Yelena Kemel, Zsofia K Stadler, Vijai Joseph, Ahmet Zehir, Nisha Pradhan, Angela Arnold, Michael F Walsh, Yirong Li, Anoop R Balakrishnan, Aijazuddin Syed, Meera Prasad, Khedoudja Nafa, Maria I Carlo, Karen A Cadoo, Meg Sheehan, Megan H Fleischut, Erin Salo-Mullen, Magan Trottier, Steven M Lipkin, Anne Lincoln, Semanti Mukherjee, Vignesh Ravichandran, Roy Cambria, Jesse Galle, Wassim Abida, Marcia E Arcila, Ryma Benayed, Ronak Shah, Kenneth Yu, Dean F Bajorin, Jonathan A Coleman, Steven D Leach, Maeve A Lowery, Julio Garcia-Aguilar, Philip W Kantoff, Charles L Sawyers, Maura N Dickler, Leonard Saltz, Robert J Motzer, Eileen M O'Reilly, Howard I Scher, Jose Baselga, David S Klimstra, David B Solit, David M Hyman, Michael F Berger, Marc Ladanyi, Mark E Robson, Kenneth Offit. JAMA 2017
Times Cited: 185




List of shared articles



Times cited


Use of Treatment-Focused Tumor Sequencing to Screen for Germline Cancer Predisposition.
Tammy T Y Lau, Christina M May, Zahra J Sefid Dashti, Lucas Swanson, Elizabeth R Starks, Jeremy D K Parker, Richard A Moore, Tracy Tucker, Ian Bosdet, Sean S Young,[...]. J Mol Diagn 2021
0

A Retrospective 5-Year Single Center Study Highlighting the Risk of Cancer Predisposition in Adolescents and Young Adults.
Frank Jordan, Simon Huber, Sebastian Sommer, Gerhard Schenkirsch, Michael C Frühwald, Martin Trepel, Rainer Claus, Michaela Kuhlen. Cancers (Basel) 2021
0

Identification of the TP53 p.R337H Variant in Tumor Genomic Profiling Should Prompt Consideration of Germline Testing for Li-Fraumeni Syndrome.
Renata Lazari Sandoval, Cibele Masotti, Mariana Petaccia de Macedo, Maurício Fernando Silva Almeida Ribeiro, Ana Carolina Rathsam Leite, Sibele Inacio Meireles, Rodrigo Medeiros Bovolin, Fernando Costa Santini, Rodrigo Ramella Munhoz, Denis Leonardo Fontes Jardim,[...]. JCO Glob Oncol 2021
0


Clinical significance of TP53 variants as possible secondary findings in tumor-only next-generation sequencing.
Yoshihiro Yamamoto, Masashi Kanai, Tadayuki Kou, Aiko Sugiyama, Eijiro Nakamura, Hidehiko Miyake, Takahiro Yamada, Masakazu Nishigaki, Tomohiro Kondo, Hiromi Murakami,[...]. J Hum Genet 2020
1

Current Approaches to Germline Cancer Genetic Testing.
Elena M Stoffel, John M Carethers. Annu Rev Med 2020
3

Evolving Significance of Tumor-Normal Sequencing in Cancer Care.
Diana Mandelker, Ozge Ceyhan-Birsoy. Trends Cancer 2020
3

Redefining Colorectal Cancer by Tumor Biology.
Mohamed E Salem, Alberto Puccini, Jeanne Tie. Am Soc Clin Oncol Educ Book 2020
4

Genetic Counseling and Germline Testing in the Era of Tumor Sequencing: A Cohort Study.
Stefan Klek, Brandie Heald, Alex Milinovich, Ying Ni, Jame Abraham, Haider Mahdi, Bassam Estfan, Alok A Khorana, Brian J Bolwell, Petros Grivas,[...]. JNCI Cancer Spectr 2020
2


Yield and Utility of Germline Testing Following Tumor Sequencing in Patients With Cancer.
Stephen E Lincoln, Robert L Nussbaum, Allison W Kurian, Sarah M Nielsen, Kingshuk Das, Scott Michalski, Shan Yang, Nhu Ngo, Amie Blanco, Edward D Esplin. JAMA Netw Open 2020
5